Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atrial Fibrillation (Prevention of Stroke)”

122 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 122 results

Not applicableStudy completedNCT02960880
What this trial is testing

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Who this might be right for
Atrial Fibrillation
Bayer 99,999
Not applicableLooking for participantsNCT07036965
What this trial is testing

Comparison of Different Pulsed Field Ablation Catheters in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)
Hangzhou Dinova EP Technology Co., Ltd 292
Not applicableStudy completedNCT01090362
What this trial is testing

Global Anticoagulant Registry in the Field

Who this might be right for
Atrial Fibrillation
Thrombosis Research Institute 57,250
Not applicableStudy completedNCT03242278
What this trial is testing

Real-world Dosing Patterns of Rivaroxaban in the United States

Who this might be right for
Atrial Fibrillation
Bayer 12,507
Not applicableStudy completedNCT02690155
What this trial is testing

Real-world Comparative Effectiveness of Rivaroxaban Versus VKA

Who this might be right for
Atrial Fibrillation
Bayer 38,831
Not applicableLooking for participantsNCT07224178
What this trial is testing

Left Atrial Strain and Cryptogenic Stroke

Who this might be right for
Ischemic Stroke, CryptogenicIschemic Stroke, EmbolicHemorrhagic Stroke+2 more
University of Pittsburgh 900
Not applicableStudy completedNCT02714855
What this trial is testing

Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 2,081
Not applicableUnknownNCT02743416
What this trial is testing

Systematic NT-proBNP and ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm, Sweden - STROKESTOP II

Who this might be right for
Atrial FibrillationStroke
Karolinska University Hospital 6,868
Early research (Phase 1)Study completedNCT05419635
What this trial is testing

Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver Function

Who this might be right for
Prevention of Thromboembolic EventsAtrial FibrillationAcute Myocardial Infarction+2 more
Bayer 27
Not applicableUnknownNCT03327350
What this trial is testing

WATCHMAN for Second Prevention of Stroke (WASPS)

Who this might be right for
Atrial FibrillationStroke
Second Affiliated Hospital, Zhejiang University, School of Medicine 400
Post-approval studies (Phase 4)UnknownNCT01461434
What this trial is testing

Graz Study on the Risk of Atrial Fibrillation

Who this might be right for
Atrial FibrillationHypertensionDiabetes+2 more
Medical University of Graz 82
Not applicableStudy completedNCT02956343
What this trial is testing

SmartWATCHes for Detection of Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
University Hospital, Basel, Switzerland 651
Large-scale testing (Phase 3)Study completedNCT03996772
What this trial is testing

PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation

Who this might be right for
Atrial FibrillationIntracerebral Hemorrhage
Imperial College London 319
Not applicableStudy completedNCT03847181
What this trial is testing

Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice

Who this might be right for
Atrial Fibrillation
Bayer 45,164
Not applicableStudy completedNCT03374540
What this trial is testing

Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

Who this might be right for
Nonvalvular Atrial Fibrillation
Bayer 78,517
Not applicableStudy completedNCT02958943
What this trial is testing

Electronic Alerts for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial FibrillationStroke
Brigham and Women's Hospital 798
Not applicableUnknownNCT01522911
What this trial is testing

Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage

Who this might be right for
Atrial FibrillationStroke PreventionLeft Atrial Appendage
University of Leipzig 50
Not applicableLooking for participantsNCT07407790
What this trial is testing

The Southern-Norway Post-Stroke Atrial Fibrillation Study

Who this might be right for
Atrial Fibrillation (AF)Atrial Fibrillation (Prevention of Stroke)Ischemic Stroke+2 more
Sorlandet Hospital HF 450
Not applicableStudy completedNCT02784717
What this trial is testing

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

Who this might be right for
Stroke
Bayer 3,055
Post-approval studies (Phase 4)Looking for participantsNCT03968393
What this trial is testing

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

Who this might be right for
StrokeAtrial Fibrillation
Population Health Research Institute 2,270
Next Page